Skip to main content
Hit enter to search or ESC to close
Close Search
Menu
Company
Company Overview
Corporate Presentation
Leadership
Core Principles
Collaborations
Platform
CNP Overview
Cellular Nanonsponge
CNP Drug Delivery
Publications
Pipeline
Pipeline
CTI-005
CTI-111
Pipeline Expansion & CNP Drug Delivery
Newsroom
Press Releases
Featured Media
Presentations
Media Contact
News Alerts
Careers
Contact
Newsroom
Press Releases and Multimedia
Press Releases
Featured Media
Presentations
Media Contact
News Alerts
Press Releases
Cellics Therapeutics Announces Appointment of Paul Daruwala as President and CEO
September 12, 2022
Cellics Therapeutics Receives First IND Allowance by FDA for its Innovative Cellular Nanoparticle (CNP) Technology
March 3, 2022
Cellics Announces the Receipt of CARB-X Award of Up to US$15 Million
October 21, 2021
Cellics Therapeutics Announces the Publication of Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity in Nano Letters
June 17, 2020
Featured Media
Custom Engineered Nanoparticles [via Science Nation]
February 27, 2017
Nanosponges Soak Up Toxins from Bacteria and Venom [UC San Diego]
April 14, 2013
Presentations
Corporate Presentation
November 27, 2023
Media Contact
Paul Daruwala
Cellics Therapeutics
(858) 412-6148
media@cellics.com
Subscribe to Receive News Alerts
Fill out my
online form
.
Close Menu
Company
Company Overview
Corporate Presentation
Leadership
Core Principles
Collaborations
Platform
CNP Overview
Cellular Nanonsponge
CNP Drug Delivery
Publications
Pipeline
Pipeline
CTI-005
CTI-111
Pipeline Expansion & CNP Drug Delivery
Newsroom
Press Releases
Featured Media
Presentations
Media Contact
News Alerts
Careers
Contact